Effects of amyloid precursor protein derivatives and oxidative stress on basal forebrain cholinergic systems in Alzheimer's disease.
about
Inflammation and Alzheimer's diseaseCompensatory responses to age-related decline in odor quality acuity: cholinergic neuromodulation and olfactory enrichment.Neuroprotective effect of leukemia inhibitory factor on antimycin A-induced oxidative injury in differentiated PC12 cells.Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model.The amyloid precursor protein (APP) family members are key players in S-adenosylmethionine formation by MAT2A and modify BACE1 and PSEN1 gene expression-relevance for Alzheimer's disease.The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice.Alterations of some membrane transport proteins in Alzheimer's disease: role of amyloid beta-peptide.Bioluminescence imaging reveals inhibition of tumor cell proliferation by Alzheimer's amyloid beta proteinThe role of iron as a mediator of oxidative stress in Alzheimer disease.The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD.Implication of matrix metalloproteinases in regulating neuronal disorder.Selective and biphasic effect of the membrane lipid peroxidation product 4-hydroxy-2,3-nonenal on N-methyl-D-aspartate channels.Role of nitric oxide in ethanol-induced up-regulation of muscarinic acetylcholine receptors in SH-SY5Y cells.Walnut supplementation reverses the scopolamine-induced memory impairment by restoration of cholinergic function via mitigating oxidative stress in rats: a potential therapeutic intervention for age related neurodegenerative disorders.Plasma levels of neuropeptides in Alzheimer's disease.A case for a non-transgenic animal model of Alzheimer's disease.Effect of Cinnamomum zeylanicum extract on scopolamine-induced cognitive impairment and oxidative stress in rats.Prevention of β-Amyloid Neurotoxicity by Blockade of the Ubiquitin-Proteasome Proteolytic Pathway
P2860
Q28138617-60AA10F3-BA0A-4A6E-B721-076C3D20E33EQ33938909-27E884F5-1D6C-4B52-A5AF-0CB6A808AB92Q34699493-05E6D686-90C1-4F40-A8BF-56B35369DD8EQ34918986-971F8FFB-5DF9-46C3-B97A-7F0CC1A9E5DBQ36386855-02112FEB-8F9D-4777-97BC-9D96F8A2A27DQ36686413-3466428F-D3F1-4B1E-9859-611B6FFF2E5BQ37030598-91E4DCA0-8452-4E3A-BEC9-E77594CD00E0Q37240159-277C504F-6E53-41F2-8A51-1F16AB649FA8Q37996961-8CD143DE-BE37-4103-8055-B3BCC148BDC2Q38094984-CADF38AB-D3E9-4E2E-98FC-A171AA4BE65FQ38265490-C9C87489-55D9-44E7-8B1C-2E6EDD94DEC6Q43694497-DCDE2B9A-8C2A-443F-A348-1606037007E1Q43707088-DB115BD1-B202-4097-BE16-9C3B4A27B42AQ45069944-1C738174-5659-4F5B-8663-FC25A36C5A1EQ48523529-4185A40C-C5BE-42F5-9A8C-11E87E382AEFQ48943001-64E64964-853A-4E65-8181-D5196561DF63Q50686924-8AFB6F75-3973-4447-A2E4-5AAE3835A77EQ58331705-5FA27EFE-85A3-4405-88F0-AB9DE3B0AE7F
P2860
Effects of amyloid precursor protein derivatives and oxidative stress on basal forebrain cholinergic systems in Alzheimer's disease.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Effects of amyloid precursor p ...... ystems in Alzheimer's disease.
@ast
Effects of amyloid precursor p ...... ystems in Alzheimer's disease.
@en
type
label
Effects of amyloid precursor p ...... ystems in Alzheimer's disease.
@ast
Effects of amyloid precursor p ...... ystems in Alzheimer's disease.
@en
prefLabel
Effects of amyloid precursor p ...... ystems in Alzheimer's disease.
@ast
Effects of amyloid precursor p ...... ystems in Alzheimer's disease.
@en
P1476
Effects of amyloid precursor p ...... ystems in Alzheimer's disease.
@en
P2093
Mattson MP
Pedersen WA
P304
P356
10.1016/S0736-5748(98)00082-3
P577
1998-11-01T00:00:00Z